Skip To Content
JEWISH. INDEPENDENT. NONPROFIT.
Breaking News

Demjanjuk’s Family Appeal Decision on Death

The family of John Demjanjuk appealed the decision by German prosecutors to close an investigation into the convicted Nazi war criminal’s death.

Prosecutors in the German state of Bavaria late last month determined that Demjanjuk’s death was not hastened by medication administered at a nursing home in Bavaria. Demjanjuk died while he was awaiting an appeal of his conviction last year by a Munich court for his role in the murder of 27,900 people at the Sobibor camp in Poland.

Ulrich Busch, an attorney for Demjanjuk, filed an appeal on Tuesday that said the decision contradicts “all medical knowledge” about the drug Novalgin, which was used to treat Demjanjuk, according to The Associated Press. The drug is common in Germany but banned in the United States and other countries.

Busch had filed a complaint in May with German prosecutors asking them to open an investigation of five doctors and a nurse, alleging that the pain medication they gave to Demjanjuk added to his kidney problems. Demjanjuk died in March at 91.

A message from our CEO & publisher Rachel Fishman Feddersen

I hope you appreciated this article. Before you go, I’d like to ask you to please support the Forward’s award-winning, nonprofit journalism during this critical time.

At a time when other newsrooms are closing or cutting back, the Forward has removed its paywall and invested additional resources to report on the ground from Israel and around the U.S. on the impact of the war, rising antisemitism and polarized discourse..

Readers like you make it all possible. Support our work by becoming a Forward Member and connect with our journalism and your community.

—  Rachel Fishman Feddersen, Publisher and CEO

Join our mission to tell the Jewish story fully and fairly.

Republish This Story

Please read before republishing

We’re happy to make this story available to republish for free, unless it originated with JTA, Haaretz or another publication (as indicated on the article) and as long as you follow our guidelines. You must credit the Forward, retain our pixel and preserve our canonical link in Google search.  See our full guidelines for more information, and this guide for detail about canonical URLs.

To republish, copy the HTML by clicking on the yellow button to the right; it includes our tracking pixel, all paragraph styles and hyperlinks, the author byline and credit to the Forward. It does not include images; to avoid copyright violations, you must add them manually, following our guidelines. Please email us at [email protected], subject line “republish,” with any questions or to let us know what stories you’re picking up.

We don't support Internet Explorer

Please use Chrome, Safari, Firefox, or Edge to view this site.